A secure web portal with data exchange capabilities is not enough – document storage and retrieval features need to be added to the feature mix for real value addition.
Regarding serialization, there exist a number of questions that need to be answered directly by the FDA. If companies chooses not to randomize, they run the risk of having someone in the supply chain.
Know how to Handle DSCSA Exceptions as a pharmaceutical company or as a manufacturer, a re-packager, distributor or a dispenser.
Know how to choose the appropriate ERP solution partner for your pharmaceutical company and meet the DSCSA compliance requirements with ease.
Use the Extension in Deadline for DSCSA Data Exchange Enforcement to Your Advantage. Be a leader in the pharmaceutical industry.
One of the questions we get at TrackTraceRx is, “how do I notify the FDA if i discover a counterfeit product within my supply chain?”. Get there answer here.
Understanding the Drug Supply Chain Security Act (DSCSA) is important to sustain in the pharmaceutical industry. Get all the details here.
Before trying to making sense of the FDA’s definition of the ‘interoperability’, it’s worth revisiting the DSCSA timeline for data exchange
HDA Updates their Q/A for the DSCSA. Know about it in details about the traceability aspects.
Take a closer look at the 3T’s and the master data reveals that the poor quality of the master data manifests itself in the Transaction Information.
Shaping the future of traceability and serialization since 2007
